Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-16-017712

Chief Scientific Officer & EVP sold 61,000 shares at an average $26.16 ($1,595,586)

From the SEC's structured data for this filing

Trades in this filing

COOK DAVID N · Chief Scientific Officer & EVP

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-04-01 Sale : show line 1 in the form −46,650 $25.74 $1,200,771 183,023 D
2016-04-01 Sale : show line 2 in the form −6,350 $26.90 $170,815 176,673 D
2016-04-04 Sale : show line 3 in the form −8,000 $28.00 $224,000 168,673 D
Open-market sales · 61,000 sh · avg $26.16 · $1,595,586
Loading xslF345X03/doc4.xml…